James D. Lewis, M.D., M.S.C.E.
Professor of Medicine
Senior Fellow, Leonard Davis Institute of Health Economics, University of Pennsylvania
Senior Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania
Associate Director, Inflammatory Bowel Disease Program, University of Pennsylvania, University of Pennsylvania
Department: Medicine
Graduate Group Affiliations
Contact information
University of Pennsylvania
Division of Gastroenterology
Center for Clinical Epidemiology and Biostatistics
720 Blockley Hall
423 Guardian Drive
Philadelphia, PA 19104-6021
Division of Gastroenterology
Center for Clinical Epidemiology and Biostatistics
720 Blockley Hall
423 Guardian Drive
Philadelphia, PA 19104-6021
Office: (215) 573-5137
Fax: (215) 573-0813
Fax: (215) 573-0813
Email:
lewisjd@mail.med.upenn.edu
lewisjd@mail.med.upenn.edu
Publications
Education:
BA (Interdisciplinary Studies)
University of Virginia, 1987.
MD
University of Pennsylvania, 1991.
MSCE (Clinical Epidemiology)
University of Pennsylvania, 1998.
BA (Interdisciplinary Studies)
University of Virginia, 1987.
MD
University of Pennsylvania, 1991.
MSCE (Clinical Epidemiology)
University of Pennsylvania, 1998.
Post-Graduate Training
Intern in Internal Medicine, Yale-New Haven Hospital, New Haven, CT, 1991-1992.
Resident in Internal Medicine, Yale - New Haven Hospital, New Haven, CT, 1992-1994.
Chief Resident in Internal Medicine, Yale - New Haven Hospital, New Haven, CT, 1994-1995.
Fellow in Gastroenterology, Hospital of the University of Pennsylvania, Philadelphia, PA, 1995-1998.
Pharmacoepidemiology Fellow, University of Pennsylvania, Philadelphia, PA, 1996-1998.
Permanent linkIntern in Internal Medicine, Yale-New Haven Hospital, New Haven, CT, 1991-1992.
Resident in Internal Medicine, Yale - New Haven Hospital, New Haven, CT, 1992-1994.
Chief Resident in Internal Medicine, Yale - New Haven Hospital, New Haven, CT, 1994-1995.
Fellow in Gastroenterology, Hospital of the University of Pennsylvania, Philadelphia, PA, 1995-1998.
Pharmacoepidemiology Fellow, University of Pennsylvania, Philadelphia, PA, 1996-1998.
Description of Research Expertise
Epidemiology, IBD, Colon CancerDescription of Clinical Expertise
Gastroenterology, IBD, Colon CancerSelected Publications
Goldberg D, Lewis JD, Halpern SD, Weiner M, Lo Re V: Validation of three coding algorithms to identify patients with end-stage liver disease in an administrative database. Pharmacoepidemiol Drug Saf 22(1): 103-7, Jan 2013Bewtra M, Kaiser LM, Tenhave T, Lewis JD: Crohn's disease and ulcerative colitis are associated with elevated standardized mortality ratios: a meta-analysis. Inflamm Bowel Dis 19(3): 599-613, Mar 2013.
Aberra FN, Lewis JD: As in the chicken or the egg: stress or inflammatory bowel disease? Clinical Gastroenterology and Hepatology 11(1): 63-4, Jan 2013.
Winthrop KL, Chen L, Fraunfelder FW, Ku JH, Varley CD, Suhler E, Hills WL, Gattey D, Baddley JW, Liu L, Grijalva CG, Delzell E, Beukelman T, Patkar NM, Xie F, Herrinton LJ, Fraunfelder FT, Saag KG, Lewis JD, Solomon DH, Curtis JR.: Initiation of Anti-TNF Therapy and the Risk of Optic Neuritis; From the Safety Assessment of Biologic ThERapy (SABER) Study. American Journal of Ophthalmology 155(1): 183-189, Jan 2013.
Haynes K, Beukelman T, Curtis JR, Newcomb C, Herrinton LJ, Graham DJ, Solomon DH, Griffin MR, Chen L, Liu L, Saag KG, Lewis JD on behalf of the Safety Assessment of Biological thERapeutics (SABER) Collaboration : Tumor necrosis factor alpha inhibitor therapy and cancer risk in chronic immune mediated diseases. Arthritis and Rheumatism 65(1): 48-58, Jan 2013.
Herrinton LJ, Liu L, Chen L, Harrold LR, Raebel MA, Curtis JR, Griffin MR, Solomon DH, Saag KG, Lewis JD: Association between anti-TNF-α therapy and all-cause mortality Pharmacoepidemiology and Drug Safety 21(12): 1311-20, Dec 2012.
Kronman MP, Zaoutis TE, Haynes K, Feng R, Coffin SE: Antibiotic exposure and IBD development among children: A population-based cohort study. Pediatrics 130(4): e794-e803, October 2012.
Mamtani R, Haynes K, Bilker WB, Vaughn DJ, Strom BL, Glanz K, Lewis JD: Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study. J Natl Cancer Inst 104(18): 1411-21, Sep 2012.
Scott F, Osterman MT, Mahmoud MM, Lewis JD.: Secular Trends in Small Bowel Obstruction and Adhesiolysis in the United States, 1988-2007. American Journal of Surgery 204(3): 315-320, Sept 2012.
Toedter G, Li K, Sague S, Ma K, Marano C, Macoritto M, Park J, Deehan R, Matthews A, Wu GD, Lewis JD, Arijs I, Rutgeerts P, Baribaud F: Genes Associated with Intestinal Permeability in Ulcerative Colitis: Changes in Expression Following Infliximab Therapy. Inflammatory Bowel Diseases 18(8): 1399-1410, Aug 2012.
